The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 6 p63 TA1 Binds to the Oligomerization Domain of p63 (A) SEC chromatogram of His-MBP-ΔNp63αPPR purified from E. coli lacking the last 25 unstructured residues. The apparent molecular weight is indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. (B) Chemical shift perturbations (CSPs) on p63 OD (color coded) and p63 TD (gray) after addition of p63 TA1. OD residues are colored in blue, those with CSP >0.1 ppm are shown in red and those with CSPs >0.05 ppm are shown in orange. (C and D) [15N,1H]-TROSY spectra of 15N-labeled p63 OD in presence (red) and absence (blue) of p63 TA1 (C) and of p63 TA1FWL (D). (E) Model of p63 TD based on the structure of human p73 TD. Residues are colored according to the code in (B). Helix H2 of the TD (white) lies on top of the TA1-OD interaction interface. H2 is either shown as a ribbon or as a space-filling model. (F) Sequences of p63 TA1 and p63 TA1FWL with the additional F10W mutation for UV280nm-based quantification. (G and H) Western blot (G) and corresponding bar diagram (H) of SEC elution fractions between 1.05 and 1.70 ml of TAp63αFWL expressed in RRL using an anti-myc antibody. (I and J) Western blot (I) and corresponding bar diagram (J) of pull-down experiments with TAp63αFWL and ΔNp63α from RRL using immobilized TA domain. Input (IP) and pull-down (PD) for each protein are shown in (I). For comparison, pull-down results for TAp63α and TAp63γ from Figure 5H are shown. Error bars show standard deviation.](/paper-figures/102fe7a7a409480eb9bdca63a6e3b1a8/dna-damage-in-oocytes-induces-a-switch-of-the-quality-control-factor-tap63-from-figure-6.jpg)



![Figure S3 DNA Binding of TAp63 Is Specific, whereas λ-Phosphatase Treatment Leads to Complete Dephosphorylation, Related to Figure 3 (A and B) Binding of MBP-TAp63α (black dots), MBP-TAp63αFTL (red dots), MBP-TAp63γ (blue dots) and MBP-TAp63αR (purple dots) purified from E. coli to 300 nM of SELEX DNA (see Methods section) (A) or to a random sequence (see Methods section) (B) using fluorescence anisotropy. In (A) all TAp63 forms except MBP-TAp63αR bind to the SELEX DNA, with MBP-TAp63αFTL and MBP-TAp63γ showing higher affinity than MBP-TAp63α. In (B) none of the TAp63 forms binds to the random sequence. (C) In vitro phosphorylation assay in which MBP-TAp63α purified from E. coli (lanes 1; 3-8) was incubated in the absence (lane 1) or presence (lanes 2-8) of lysed IRR ovaries (lane 2) for 30 min at RT with 10 μCi [γ-32P]-ATP. The reaction was challenged by 5 U λ-phosphatase (λ-PP) (lane 4), phosphatase inhibitors (Lane 5), 100 μM ATP (lane 6), 100 μM GTP (lane 7) or 100 μM ADP (lane 8). Reactions were stopped by SDS sample buffer and the samples were analyzed on 10% SDS-PAGE. The phosphorylation profile was visualized by autoradiography. (D) Coomassie staining of the gel corresponding to (C) showing MBP-TAp63α as loading control.](/paper-figures/feac40a1b87a417688a1bbab0f3ef5e3/dna-damage-in-oocytes-induces-a-switch-of-the-quality-control-factor-tap63-from-figure-11.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although all transcriptionally active forms of the mammalian p53 protein family are tetrameric (Luh et al. 2013), TAp63a in oocytes forms inactive dimers (Fig. 3B) (Deutsch et al. 2011).”
From Structural Evolution and Dynamics of the p53 Proteins (2017) · cites this paper as Deutsch et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia
Senoo, M., Pinto, F., Crum, C. P., & McKeon, F. (2007) · Cell · doi:10.1016/j.cell.2007.02.045 · Cited by 881 · cited 2×
“development of stratified epithelial tissues including skin by maintaining a stem cell population in the basal layer (Senoo et al., 2007).”
BackgroundSelf-citationPRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Research works printed but not linked: 39
- Brandt, 2009, Conservation of DNA-binding specificity and oligomerisation properties within the p53 family, BMC Genomics, 10, 628, 10.1186/1471-2164-10-628 · DOI · Paper page
- Burge, 2009, Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation, Proc. Natl. Acad. Sci. USA, 106, 3142, 10.1073/pnas.0900383106 · DOI
- Celli, 1999, Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome, Cell, 99, 143, 10.1016/S0092-8674(00)81646-3 · DOI · Paper page
- Chan, 2004, How many mutant p53 molecules are needed to inactivate a tetramer?, Mol. Cell. Biol., 24, 3536, 10.1128/MCB.24.8.3536-3551.2004 · DOI · Paper page
- Chene, 2001, The role of tetramerization in p53 function, Oncogene, 20, 2611, 10.1038/sj.onc.1204373 · DOI · Paper page
- Cole, 2004, Analysis of heterogeneous interactions, Methods Enzymol., 384, 212, 10.1016/S0076-6879(04)84013-8 · DOI
- Coutandin, 2009, Conformational stability and activity of p73 require a second helix in the tetramerization domain, Cell Death Differ., 16, 1582, 10.1038/cdd.2009.139 · DOI
- Coutandin, 2010, Tracing the protectors path from the germ line to the genome, Proc. Natl. Acad. Sci. USA, 107, 15318, 10.1073/pnas.1001069107 · DOI
- Davison, 2001, Structure and functionality of a designed p53 dimer, J. Mol. Biol., 307, 605, 10.1006/jmbi.2001.4450 · DOI
- De Laurenzi, 1999, Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta, Cell Death Differ., 6, 389, 10.1038/sj.cdd.4400521 · DOI
- Derry, 2001, Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance, Science, 294, 591, 10.1126/science.1065486 · DOI · Paper page
- Guo, 2009, TAp63 induces senescence and suppresses tumorigenesis in vivo, Nat. Cell Biol., 11, 1451, 10.1038/ncb1988 · DOI · Paper page
- Hoffmann, 2009, Probing the limits of liquid droplet laser desorption mass spectrometry in the analysis of oligonucleotides and nucleic acids, Rapid Commun. Mass Spectrom., 23, 2176, 10.1002/rcm.4129 · doi:10.1002/rcm.4129
- Horikoshi, 1995, Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression, Mol. Cell. Biol., 15, 227, 10.1128/MCB.15.1.227 · DOI · Paper page
- Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
- Joerger, 2009, Structural evolution of p53, p63, and p73: implication for heterotetramer formation, Proc. Natl. Acad. Sci. USA, 106, 17705, 10.1073/pnas.0905867106 · DOI
- Kaghad, 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 · DOI · Paper page
- Lebowitz, 2002, Modern analytical ultracentrifugation in protein science: a tutorial review, Protein Sci., 11, 2067, 10.1110/ps.0207702 · DOI · Paper page
- Lee, 1994, Solution structure of the tetrameric minimum transforming domain of p53, Nat. Struct. Biol., 1, 877, 10.1038/nsb1294-877 · DOI · Paper page
- Lu, 1995, Human TAFII31 protein is a transcriptional coactivator of the p53 protein, Proc. Natl. Acad. Sci. USA, 92, 5154, 10.1073/pnas.92.11.5154 · DOI · Paper page
- McGrath, 2001, Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63, Hum. Mol. Genet., 10, 221, 10.1093/hmg/10.3.221 · DOI · Paper page
- Mills, 1999, p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, 398, 708, 10.1038/19531 · DOI · Paper page
- Morgner, 2007, A novel approach to analyze membrane proteins by laser mass spectrometry: from protein subunits to the integral complex, J. Am. Soc. Mass Spectrom., 18, 1429, 10.1016/j.jasms.2007.04.013 · DOI
- Ortt, 2006, Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53, FEBS Lett., 580, 4544, 10.1016/j.febslet.2006.07.004 · DOI
- Ou, 2007, Structural evolution of C-terminal domains in the p53 family, EMBO J., 26, 3463, 10.1038/sj.emboj.7601764 · DOI
- Pearson, 2010, A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages, Development, 137, 213, 10.1242/dev.044297 · DOI · Paper page
- Rossi, 2006, The E3 ubiquitin ligase Itch controls the protein stability of p63, Proc. Natl. Acad. Sci. USA, 103, 12753, 10.1073/pnas.0603449103 · DOI · Paper page
- Schleiff, 2003, A GTP-driven motor moves proteins across the outer envelope of chloroplasts, Proc. Natl. Acad. Sci. USA, 100, 4604, 10.1073/pnas.0730860100 · DOI
- Schmale, 1997, A novel protein with strong homology to the tumor suppressor p53, Oncogene, 15, 1363, 10.1038/sj.onc.1201500 · DOI · Paper page
- Senoo, 1998, A second p53-related protein, p73L, with high homology to p73, Biochem. Biophys. Res. Commun., 248, 603, 10.1006/bbrc.1998.9013 · DOI
- Serber, 2002, A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism, Mol. Cell. Biol., 22, 8601, 10.1128/MCB.22.24.8601-8611.2002 · DOI · Paper page
- Straub, 2010, The C-terminus of p63 contains multiple regulatory elements with different functions, Cell Death Dis., 1, e5, 10.1038/cddis.2009.1 · DOI
- Suh, 2006, p63 protects the female germ line during meiotic arrest, Nature, 444, 624, 10.1038/nature05337 · DOI · Paper page
- Thut, 1995, p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
- Trink, 1998, A new human p53 homologue, Nat. Med., 4, 747, 10.1038/nm0798-747 · DOI · Paper page
- Yang, 1998, p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
- Yang, 1999, p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development, Nature, 398, 714, 10.1038/19539 · DOI · Paper page
- Yang, 2000, p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours, Nature, 404, 99, 10.1038/35003607 · DOI · Paper page
- Ying, 2005, DNA-binding and transactivation activities are essential for TAp63 protein degradation, Mol. Cell. Biol., 25, 6154, 10.1128/MCB.25.14.6154-6164.2005 · DOI
Cited by
p53: 800 million years of evolution and 40 years of discovery
Levine, A. J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0262-1 · Cited by 826
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, A. C., & Fersht, A. R. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014710 · Cited by 661
Genetic insights into biological mechanisms governing human ovarian ageing
Ruth, K. S., Day, F. R., Hussain, J., Martínez-Marchal, A., Aiken, C. E., Azad, A., Thompson, D. J., Knoblochova, L., Abe, H., Tarry-Adkins, J. L., et al. (2021) · Nature · doi:10.1038/s41586-021-03779-7 · Cited by 428
Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases
Uversky, V. N., Davé, V., Iakoucheva, L. M., Malaney, P., Metallo, S. J., Pathak, R. R., & Joerger, A. C. (2014) · Chemical Reviews · doi:10.1021/cr400713r · Cited by 288
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F. D., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252
Self-citation
Metadata
- Authors
- Deutsch, G. B., Zielonka, E. M., Coutandin, D., Weber, T. A., Schäfer, B., Hannewald, J., Luh, L. M., Durst, F. G., Ibrahim, M., Hoffmann, J., Niesen, F. H., Sentürk, A., Kunkel, H., Brutschy, B., Schleiff, E., Knapp, S., Acker-Palmer, A., Grez, M., McKeon, F., & Dötsch, V.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 144
- Issue
- 4
- Pages
- 566-576
- ISSN
- 0092-8674
- PMC
- PMC3087504
- Cited by
- 131
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/3.0/ (vor, 896 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.